These findings partly agree with the effect of the MAPT H1 haplotype on longitudinal volume loss in de novo PD, largely in the frontal cortex (Sampedro et al., 2018b), which is an element of the LFPN. This evidence concerns the gene MAPT and Parkinson disease.